Advertisement

Picture EBD Group BioTech Showcase 2020 San Francisco BEU2020 650x76px
Document › Details

Asahi Kasei Corporation. (11/25/19). "Press Release: Presentation – Accelerating Transformation into a Global Health Care Company. Acquisition of U.S.-based Veloxis Pharmaceuticals Inc.". Tokyo.

Organisations Organisation Veloxis Pharmaceuticals A/S (Nasdaq OMX Copenhagen: VELO)
  Today LifeCycle Pharma A/S
  Organisation 2 Asahi Kasei Pharma Denmark A/S
  Group Asahi Kasei (Group)
Products Product MeltDose® drug delivery technology
  Product 2 Envarsus XR
Index term Index term Veloxis Pharmaceuticals–Asahi Kasei: investment, 201911– recommended cash offer DKK 8.9b ($1.3b) by Asahi Kasei Pharma Denmark A/S
Persons Person Collard, Craig (Veloxis Pharmaceuticals 201911 CEO)
  Person 2 Kobori, Hideki (Asahi Kasei 201709 President + Representative Director of Asahi Kasei Corp)
     


   
Record changed: 2019-11-27

Advertisement

Picture [LSA] Life-Sciences-Asia.com – The Business Web Portal 650x89px

More documents for Veloxis Pharmaceuticals A/S (Nasdaq OMX Copenhagen: VELO)


To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]

Advertisement

Picture EBD Group BioTech Showcase 2020 San Francisco BEU2020 650x76px




» top